Medartis Holding AG (SWX:MED)

Market Cap	901.12M -4.5%
Revenue (ttm)	269.26M +19.8%
Net Income	8.35M +136.7%
EPS	0.67 +139.3%
Shares Out	12.45M
PE Ratio	108.06
Forward PE	50.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,295
Open	73.90
Previous Close	73.50
Day's Range	72.00 - 73.90
52-Week Range	71.50 - 97.50
Beta	1.18
Analysts	Buy
Price Target	95.00 (+31.22%)
Earnings Date	Aug 18, 2026

About Medartis Holding AG

Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company’s medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides products for the hand, wrist, forearm, elbow, shoulder, and foot and ankle, as well as for upper and lower extremities, mandible, midface, orthognathic under the APTUS and MODUS names, as well as CMX services through web portal,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1997
• Employees: 1,337
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: MED

Financial Performance

In 2025, Medartis Holding AG's revenue was 269.26 million, an increase of 19.76% compared to the previous year's 224.83 million. Earnings were 8.35 million, an increase of 136.65%.

Analyst Summary

According to 4 analysts, the average rating for MED stock is "Buy." The 12-month stock price target is CHF 95.00, which is an increase of 31.22% from the latest price.

Price Target

CHF 95.00

(31.22% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 23, 2026

Data Sources Report a data error